The objective of this study is to explore the subject clinical profiles, procedural details and post-implant outcomes of patients who receive either the CanGaroo ECM Envelope or no envelope at the time of initial implantation.
Contact phone
Sparrow Clinical Research Institute | 517.364.5760
Contact email
Principal investigator
Dr. John Ip, MD, FACC
Trial Category
Heart & Vascular
Trial SubCategory
Atrial Fibrillation